Evidence map›Paper›PMID 42871621›Full record

ArticleHIV/AIDS (Auckland, N.Z.)2026

The Future of Newly Diagnosed HIV Cases in Iran Through 2030: A Mixed-Methods Trend Impact Analysis.

AliAkbar Haghdoost, Mostafa Hosseini Golkar, Hamid Sharifi, Farid Najafi, Alireza Alikhani

Abstract read
In one paragraph

Article in HIV/AIDS (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

AliAkbar HaghdoostSocial Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.ORCID 0000-0003-4628-4849
Mostafa Hosseini GolkarSocial Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Hamid SharifiHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Farid NajafiResearch Center for Environmental Determinants of Health, Research Institute for Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.ORCID 0000-0001-8530-7180
Alireza AlikhaniSocial Development and Health Promotion Research Center, Health Policy and Promotion Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Despite substantial progress in the global HIV response, the MENA region continues to face important challenges in HIV prevention and control. In Iran, fluctuations in the number of newly diagnosed HIV cases indicate an ongoing public health challenge and underscore the need to anticipate factors that may shape future diagnosis patterns. Methods: This study applied Trend Impact Analysis (TIA) to develop conditional projections of newly diagnosed HIV cases in Iran through 2030. Monthly surveillance data from 1998 to 2023 were modeled using an ARIMA(2,0,2) to establish a baseline trend which was subsequently modified through TIA based on expert-informed estimates of the timing and magnitude of key drivers. A panel of 30 experts in HIV/AIDS, epidemiology, public health, and health policy identified and assessed key drivers that could influence future trends. Expert- informed estimates of the timing, magnitude, and persistence of impacts, were then incorporated into the baseline projection to construct alternative future scenarios. Results: Expert panels identified 13 key drivers: eight adverse influences, including conflict risk, increased sex work, new stimulant drug use, online sexual platforms, socioeconomic crises, emerging epidemics, developing sex tourism, and HIV drug resistance, expected to increase the future number of newly diagnosed HIV cases. Conversely, five positive influences, including AI healthcare, effective vaccination access, efficient surveillance toward the 95-95-95 objectives, PEP/PrEP implementation, and advanced therapies, expected to reduce the future number of newly diagnosed HIV cases. Quantitative estimates project 1698 new cases if current trends persist. Under optimistic scenarios, cases may decline by 51%, whereas pessimistic scenarios suggest an increase of 102%. The integrated TIA scenario projected an approximately 51% increase in newly diagnosed HIV cases by 2030, reaching 2558 cases by 2030, with an approximate 95% uncertainty interval of 2120-2996 (±2 SD). Conclusion: The scenario projections represent conditional future trajectories based on specified assumptions about the impact of different key drivers, The scenarios illustrate substantial uncertainty in the future number of newly diagnosed HIV cases in Iran, with scenario estimates ranging from approximately a 50% decrease to a 100% increase relative to the baseline projection.

Indexed as

health futures studiesHIV/AIDSscenario analysistrend impact analysis

Identifiers

PMID42871621
PMCPMC13660510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.